Molecular imaging in heart failure

Curr Opin Biotechnol. 2007 Feb;18(1):65-72. doi: 10.1016/j.copbio.2006.12.004. Epub 2007 Jan 3.

Abstract

Heart failure (HF), a heterogeneous syndrome of epidemic proportions, is increasingly defined by its underlying molecular and genomic alterations. Molecular cardiac imaging has emerged as a complementary discipline that has improved the understanding of the pathophysiologic principles governing experimental HF and has a potential to revolutionize assessment and management of HF in humans.

Publication types

  • Review

MeSH terms

  • 3-Iodobenzylguanidine
  • Adenoviridae / genetics
  • Genes, Reporter
  • Genetic Vectors
  • Green Fluorescent Proteins / metabolism
  • Heart Failure / physiopathology
  • Humans
  • Luciferases / metabolism
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • beta-Galactosidase / metabolism

Substances

  • Radiopharmaceuticals
  • Green Fluorescent Proteins
  • 3-Iodobenzylguanidine
  • Luciferases
  • beta-Galactosidase